| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 6.67B | 16.46% |
| Operating expense | — | — |
| Net income | 827.04M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 2696.HK returned -21.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +15.1% |
| 1 year | -21.6% |
| 5 years | +143.5% |
| All-time high | $77.90 (Aug 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2696.HK would be worth today ›No. Shanghai Henlius Biotech, Inc. has not paid a dividend in the past 12 months.
Shanghai Henlius Biotech, Inc. is part of the Healthcare sector.
Shanghai Henlius Biotech, Inc. has a market cap of 35.71B HKD, based on the latest quote.
